Physician profile
Saji Jacob
NPI 1215947585
$3,166.31
in general payments reported to CMS, 2019-2025
16 companies · $17.16 in 2025
The $17.16 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $29.28 · 2021: $1,183 · 2022: $1,338 · 2023: $160 · 2024: $214 · 2025: $17.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376 · Education: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $376.37 |
| Education | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $1,052.00 | 2022 | |
| Gilead Sciences, INC. | $1,023.75 | 2021 | |
| Intuitive Surgical, INC. | $326.02 | 2019-2024 | |
| Abbvie INC. | $207.45 | 2019-2022 | |
| Myovant Sciences INC. | $142.22 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $140.12 | 2023-2024 | Myfembree |
| Ferring Pharmaceuticals INC. | $61.82 | 2024 | Menopur |
| Myovant Sciences Gmbh | $49.44 | 2022 | |
| Smith+Nephew, INC. | $42.99 | 2023 | Stravix Pl |
| Emd Serono, INC. | $30.44 | 2020-2025 | |
| Coopersurgical, INC. | $25.90 | 2022 | |
| Janssen Pharmaceuticals, INC | $21.71 | 2021 | |
| Ethicon US, LLC | $18.06 | 2022 | |
| Hologic Sales and Service, LLC | $14.47 | 2019 | |
| Meditrina | $9.92 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saji Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.